Related Experiment Video
Updated: Feb 19, 2026

09:13
Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
Published on: July 11, 2025
30.2K
Early Gestational Hypoxia and Adverse Developmental Outcomes.
Helen E Ritchie1, Diana J Oakes1, Debra Kennedy2
1Discipline of Biomedical Science, Sydney Medical School, University of Sydney, Sydney, NSW.
Birth Defects Research
|November 7, 2017
Summary
Embryonic development involves hypoxia, but disturbed oxygen supply can cause damage. Limb defects are linked to hypoxia, especially in later gestation, and certain drug classes may increase risks.
Area of Science:
- Developmental biology
- Teratology
- Perinatology
Background:
- Hypoxia is a normal aspect of embryonic development, but can increase vulnerability to damage.
- Embryofetal responses to hypoxia vary with duration, depth, and developmental stage.
Purpose of the Study:
- To investigate the impact of hypoxia on embryonic development and malformations.
- To explore the relationship between hypoxia, specific teratogens, and birth defects.
Main Methods:
- Studied early postimplantation rat embryos' response to uterine clamping (hypoxia).
- Examined malformations induced by maternal hypoxia, uteroplacental flow interruption, and embryonic bradycardia.
- Reviewed human pregnancy data and drug effects related to hypoxia and birth defects.
Main Results:
- Early rat embryos survived longer hypoxia, while mid-gestation embryos showed high mortality after 1 hour.
- Survivors exhibited smaller size and limb reduction defects; similar patterns seen with other hypoxia models.
- High altitude pregnancies, pre-eclampsia, and certain drug exposures are associated with adverse outcomes, including limb defects.
Conclusions:
- Embryonic sensitivity to hypoxia increases with developmental stage.
- Hypoxia-induced embryonic bradycardia and associated defects highlight potential teratogenic mechanisms.
- Further research is needed to clarify the link between specific drugs and human birth defects, considering methodological limitations.
Related Concept Videos
Teratogenicity
4.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.3K
Hypoxia
2.3K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.3K
Pathophysiology of Diabetes
3.8K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.8K
Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K

